A fast test to identify microbes directly from clinical samples
Official title: Rapid Microbial ID Direct From Specimen
Funded at Pataigin, LLC · NIH-10699890 · Data updated 2026-11-12
This study is working on a fast test called BACLIB that can quickly find infections in your blood or urine in just one hour, helping doctors give you the right treatment sooner and reduce the risk of serious complications.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pataigin, LLC NIH-funded |
| Lab location | 1 site (Silver Spring, UNITED STATES) |
| Project start | July 14, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $275,712 |
| NIH project number | 1R43AI174420-01A1 |
| Project ID | NIH-10699890 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with suspected microbial infections, particularly those with positive blood cultures or urinary tract infections.
✕Less likely to help
Patients who do not have microbial infections or those whose infections are not detectable by the BACLIB test may not benefit from this research.
What this research studies
This research focuses on developing BACLIB, a rapid test that can identify microbial infections directly from clinical specimens, such as blood or urine, in just one hour. Currently, traditional microbial culture methods take a day to yield results, which delays appropriate treatment and increases the risk of complications like sepsis. BACLIB works by detecting specific microbial lipids that are abundant in bacteria and fungi, allowing for quicker and more accurate identification compared to existing tests. The goal is to create a prototype clinical assay that can be used in healthcare settings to improve patient outcomes.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time it takes to identify infections, leading to faster and more effective treatment for patients.
How similar studies have gone: Preliminary results indicate that similar rapid identification methods have shown promise, with BACLIB outperforming existing tests in accuracy.
Where this research is happening
-
Pataigin, LLC
Silver Spring, United States Active
Researchers
- Principal investigator: Nilsson, Erik J — Pataigin, LLC
- Study coordinator: Nilsson, Erik J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.